Clostridium Vaccine Market Growth is Accelerated by Rising Prevalence of Clostridium Diseases

Clostridium vaccine aids in preventing clostridial diseases including botulism, tetanus, and gas gangrene. The vaccines enhance immunity against clostridium bacteria and offer protection from severe illnesses. The global Clostridium vaccine market is driven by the rising cases of tetanus and increasing awareness regarding clostridial infections. The global Clostridium Vaccine Market is estimated to be valued at US$ 2.3 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing prevalence of clostridium diseases is one of the major factors fueling the growth of the global Clostridium vaccine market. As per World Health Organization (WHO), every year around 59,000 people die of tetanus across the globe. Most tetanus cases now occur in developing nations where vaccination coverage is low. Higher susceptibility of newborns to tetanus infection is another factor driving the demand for clostridium vaccines globally. Development of new and advanced clostridium vaccines incorporating innovative drug delivery technology and formulation is expected to present lucrative growth opportunities for market players over the forecast period.

Segment Analysis

The global Clostridium vaccine market is segmented on the basis of vaccine type and end user. Based on vaccine type, the market has been segmented into Pentavalent Clostridium vaccine and Heptavalent Clostridium vaccine. The pentavalent Clostridium vaccine segment is expected to dominate the market owing to its high effectiveness against five types of clostridium infection.

Key Takeaways

The Global Clostridium Vaccine Market Growth is expected to witness high during the forecast period of 2023 to 2030, expanding at a CAGR of 5.9%.

Regional analysis: North America is expected to be the fastest growing as well as the dominating regional market throughout the forecast period. Presence of major key players, increasing healthcare expenditure, and growing awareness regarding clostridium infections are some factors driving the growth of the Clostridium vaccine market in the region.

Key players: Key players operating in the Clostridium vaccine market are Novartis AG (Switzerland), Biogen Inc. (US), Gilead Sciences, Inc. (US), Bristol-Myers Squibb (US), Alnylam Pharmaceuticals, Inc. (US), and Sarepta Therapeutics, Inc. (US) among others. Novartis AG is expected to dominate the market owing to its strong brand presence and wide product portfolio of Clostridium vaccines.

Explore more information on this topic, Please visit -

https://www.insightprobing.com/clostridium-vaccine-market-share-and-demand-analysis/

Comments

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at US$ 2,334.2 Mn in 2024 , and is expected to exhibit a CAGR of 5.2% , in terms of revenue, over the forecast period 2024-2031 to reach US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...

Dive into insights

Search This Blog